What have we learnt from the rosiglitazone saga?

Research output: Contribution to journalArticle

10 Citations (Scopus)
Original languageEnglish (US)
Article numberd1354
Pages (from-to)666
Number of pages1
JournalBMJ
Volume342
Issue number7799
DOIs
StatePublished - Mar 26 2011

Fingerprint

rosiglitazone
Thiazolidinediones
Hypoglycemic Agents
Cardiovascular Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

What have we learnt from the rosiglitazone saga? / Montori, Victor Manuel; Shah, Nilay D.

In: BMJ, Vol. 342, No. 7799, d1354, 26.03.2011, p. 666.

Research output: Contribution to journalArticle

@article{e54eb2fee22f49aca9be0f4c62988fa4,
title = "What have we learnt from the rosiglitazone saga?",
author = "Montori, {Victor Manuel} and Shah, {Nilay D}",
year = "2011",
month = "3",
day = "26",
doi = "10.1136/bmj.d1354",
language = "English (US)",
volume = "342",
pages = "666",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7799",

}

TY - JOUR

T1 - What have we learnt from the rosiglitazone saga?

AU - Montori, Victor Manuel

AU - Shah, Nilay D

PY - 2011/3/26

Y1 - 2011/3/26

UR - http://www.scopus.com/inward/record.url?scp=79953168441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953168441&partnerID=8YFLogxK

U2 - 10.1136/bmj.d1354

DO - 10.1136/bmj.d1354

M3 - Article

C2 - 21415102

AN - SCOPUS:79953168441

VL - 342

SP - 666

JO - The BMJ

JF - The BMJ

SN - 0959-8146

IS - 7799

M1 - d1354

ER -